Regenerative medicine for cartilage

Regenerative medicine is an emerging multidisciplinary field involving biology, medicine, and engineering that is likely to revolutionize the ways we improve the health and quality of life for millions of people by restoring, maintaining, or enhancing tissue and organ function. This field holds the promise of regenerating damaged tissues and organs in the body by stimulating previously irreparable tissues to heal themselves. Regenerative medicine also includes the capacity to grow tissues and organs in the laboratory and safely implant them when the body cannot heal itself, as observed for cartilage tissue after damage or wear.

[1]  M. Ferretti,et al.  Adeno-associated viral gene transfer of transforming growth factor-β1 to human mesenchymal stem cells improves cartilage repair , 2007, Gene Therapy.

[2]  T. Gill,et al.  Healing potential of transplanted allogeneic chondrocytes of three different sources in lesions of the avascular zone of the meniscus: a pilot study , 2006, Archives of Orthopaedic and Trauma Surgery.

[3]  R Langer,et al.  Long-term culture of tissue engineered cartilage in a perfused chamber with mechanical stimulation. , 2004, Biorheology.

[4]  Christopher J Hunter,et al.  Maturation and integration of tissue-engineered cartilages within an in vitro defect repair model. , 2004, Tissue engineering.

[5]  J. Vacanti,et al.  Cartilage Engineering from Ovine Umbilical Cord Blood Mesenchymal Progenitor Cells , 2005, Stem cells.

[6]  J. Massagué,et al.  Cytostatic and apoptotic actions of TGF-β in homeostasis and cancer , 2003, Nature Reviews Cancer.

[7]  K J Gooch,et al.  IGF-I and mechanical environment interact to modulate engineered cartilage development. , 2001, Biochemical and biophysical research communications.

[8]  T. Takato,et al.  Three-dimensional microenvironments retain chondrocyte phenotypes during proliferation culture. , 2007, Tissue engineering.

[9]  A. Montag,et al.  Distinct roles of bone morphogenetic proteins in osteogenic differentiation of mesenchymal stem cells , 2007, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[10]  J. Jukes,et al.  Critical Steps toward a tissue-engineered cartilage implant using embryonic stem cells. , 2008, Tissue engineering. Part A.

[11]  Alisha Diggs,et al.  Mesenchymal stem cell-mediated gene delivery of bone morphogenetic protein-2 in an articular fracture model. , 2007, Molecular therapy : the journal of the American Society of Gene Therapy.

[12]  M. Stewart,et al.  The role of bone morphogenetic proteins in articular cartilage development, homeostasis and repair , 2007, Veterinary and Comparative Orthopaedics and Traumatology.

[13]  Andre Steinert,et al.  Gene-induced chondrogenesis of primary mesenchymal stem cells in vitro. , 2005, Molecular therapy : the journal of the American Society of Gene Therapy.

[14]  S. Bent,et al.  Chondrocytic differentiation of mesenchymal stem cells sequentially exposed to transforming growth factor‐β1 in monolayer and insulin‐like growth factor‐I in a three‐dimensional matrix , 2001, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[15]  J. Chun,et al.  Regulation of Type II Collagen Expression by Histone Deacetylase in Articular Chondrocytes* , 2007, Journal of Biological Chemistry.

[16]  Freddie H Fu,et al.  Cartilage repair using bone morphogenetic protein 4 and muscle-derived stem cells. , 2006, Arthritis and rheumatism.

[17]  M. Casal,et al.  Bone morphogenetic proteins in tissue engineering: the road from laboratory to clinic, part II (BMP delivery) , 2008, Journal of tissue engineering and regenerative medicine.

[18]  Jason A Burdick,et al.  Engineering cartilage tissue. , 2008, Advanced drug delivery reviews.

[19]  R. Ganz,et al.  Hypoxic expansion promotes the chondrogenic potential of articular chondrocytes , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[20]  Guangdong Zhou,et al.  Repair of porcine articular osteochondral defects in non-weightbearing areas with autologous bone marrow stromal cells. , 2006, Tissue engineering.

[21]  Ronald G. Crystal,et al.  Transfer of Genes to Humans: Early Lessons and Obstacles to Success , 1995, Science.

[22]  William J. O'Connor,et al.  The use of growth factors in cartilage repair. , 2000, The Orthopedic clinics of North America.

[23]  K Remberger,et al.  Enhanced repair of articular cartilage defects in vivo by transplanted chondrocytes overexpressing insulin-like growth factor I (IGF-I) , 2005, Gene Therapy.

[24]  H. Lorenz,et al.  Multilineage cells from human adipose tissue: implications for cell-based therapies. , 2001, Tissue engineering.

[25]  George Q. Daley,et al.  Prospects for Stem Cell-Based Therapy , 2008, Cell.

[26]  Dietmar W Hutmacher,et al.  Repair of large articular osteochondral defects using hybrid scaffolds and bone marrow-derived mesenchymal stem cells in a rabbit model. , 2006, Tissue engineering.

[27]  H. Pondenis,et al.  Effect of fibroblast growth factor-2 on equine mesenchymal stem cell monolayer expansion and chondrogenesis. , 2007, American journal of veterinary research.

[28]  E. Canning,et al.  A triploblast origin for Myxozoa? , 1998, Nature.

[29]  P. D. Kraan,et al.  TGF-β and osteoarthritis , 2007 .

[30]  I. Weissman,et al.  Stem Cells Units of Development, Units of Regeneration, and Units in Evolution , 2000, Cell.

[31]  G. Finkenzeller,et al.  bFGF influences human articular chondrocyte differentiation. , 2007, Cytotherapy.

[32]  W. Hao,et al.  A novel injectable scaffold for cartilage tissue engineering using adipose‐derived adult stem cells , 2008, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[33]  Freddie H Fu,et al.  Muscle derived, cell based ex vivo gene therapy for treatment of full thickness articular cartilage defects. , 2002, The Journal of rheumatology.

[34]  J. S. Park,et al.  Heparin-Bound Transforming Growth Factor-&bgr;3 Enhances Neocartilage Formation by Rabbit Mesenchymal Stem Cells , 2008, Transplantation.

[35]  G. Daculsi,et al.  Cartilage and bone tissue engineering using hydrogels. , 2006, Bio-medical materials and engineering.

[36]  A. Mikos,et al.  Gene delivery strategies for cartilage tissue engineering. , 2006, Advanced drug delivery reviews.

[37]  A J Nixon,et al.  Genetic modification of chondrocytes with insulin-like growth factor-1 enhances cartilage healing in an equine model. , 2007, The Journal of bone and joint surgery. British volume.

[38]  A. Roberts,et al.  Transforming growth factor-beta in calf articular cartilage organ cultures: synthesis and distribution. , 1991, Archives of biochemistry and biophysics.

[39]  C. Ohlsson,et al.  Treatment of deep cartilage defects in the knee with autologous chondrocyte transplantation. , 1994, The New England journal of medicine.

[40]  G. Lust,et al.  Insulin-like growth factor-I enhances cell-based repair of articular cartilage. , 2002, The Journal of bone and joint surgery. British volume.

[41]  J. Vacanti,et al.  Synthetic Polymers Seeded with Chondrocytes Provide a Template for New Cartilage Formation , 1991, Plastic and reconstructive surgery.

[42]  K. Hörmann,et al.  Human chondrocytes differentially express matrix modulators during in vitro expansion for tissue engineering. , 2005 .